Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

ClinicalTrials.gov ID: NCT04614246

Public ClinicalTrials.gov record NCT04614246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Open for Active Comparator, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Three Different Doses of P2X3 Antagonist (BAY1817080) Versus Placebo and Elagolix 150 mg in Women With Symptomatic Endometriosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess safety and efficacy of BAY 1817080 compared to elagolix and placebo in women with symptomatic endometriosis. Study details include: * Study duration: 155 up to 285 days * Treatment duration: 84 days * Visit frequency: 3 laboratory every 2 weeks for participants on BAY 1817080 or placebo

Study identification

NCT ID
NCT04614246
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
215 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2021 (Actual)
Primary completion
Jan 17, 2022 (Actual)
Completion
May 3, 2022 (Actual)
Last update posted
Aug 1, 2023

2021 – 2022

United States locations

U.S. sites
47
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Accel Research Sites - Cahaba Medical Care Birmingham Alabama 35218 —
University of Alabama at Birmingham Birmingham Alabama 35294-0026 —
Mobile Ob-Gyn, PC Mobile Alabama 36608-6703 —
Precision Trials, AZ, LLC Phoenix Arizona 85032 —
Diagnamics, Inc. Encinitas California 92024 —
West Coast OB/GYN Associates San Diego California 92123 —
Advanced Women's Health Institute Greenwood Village Colorado 80111 —
Office of Dr. James A. Simon, MD Washington D.C. District of Columbia 20036 —
Helix Biomedics, LLC Boynton Beach Florida 33435 —
Alliance for Multispecialty Research, LLC - Fort Meyers Fort Myers Florida 33912 —
Suncoast Clinical Research Center, Inc. New Port Richey Florida 34652 —
A Premier Medical Research of Florida, LLC Orange City Florida 32763 —
Physician Care Clinical Research Sarasota Florida 34239 —
Medisense, Inc. Atlanta Georgia 30363 —
Augusta University Medical Center Augusta Georgia 30912 —
Paramount Research Solutions-College Park College Park Georgia 30349 —
Journey Medical Research Snellville Georgia 30078 —
Clinical Research Prime Idaho Falls Idaho 83404 —
Southern Clinical Research Associates LLC Metairie Louisiana 70001 —
Continental Clinical Solutions, LLC Towson Maryland 21204 —
Wayne State University Physicians Group Detroit Michigan 48201 —
Essential Women's Health Associates Las Vegas Nevada 89113 —
Bosque Womens Care Albuquerque New Mexico 87109 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
Carolina Women's Research & Wellness Center Durham North Carolina 27713 —
Lyndhurst Clinical Research Winston-Salem North Carolina 27103 —
Clinical Inquest Center, Ltd. Beavercreek Ohio 45432 —
Aventiv Research - Dublin Dublin Ohio 43016 —
Centricity Research formerly Aventiv - Dublin Dublin Ohio 43016 —
HWC Women's Research Center Englewood Ohio 45322 —
University Hospitals Landerbrook Health Center Mayfield Heights Ohio 44124 —
Palmetto Clinical Research Summerville South Carolina 29485 —
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404 —
ClinSearch, LLC Chattanooga Tennessee 37421 —
Medical Research Center of Memphis, LLC Memphis Tennessee 38120 —
International Clinical Research-Tennessee LLC. Murfreesboro Tennessee 37130 —
Discovery Clinical Trials - Dallas Dallas Texas 75230 —
UT Health Women's Research Center at Memorial City Houston Texas 77024 —
Biopharma Informatic, Inc. Houston Texas 77043 —
Centex Studies, Inc. Houston Texas 77058 —
Centex Studies, Inc. Houston Texas 77090 —
Advances in Health Pearland Texas 77584 —
Tidewater Clinical Research, Inc. Norfolk Virginia 23456 —
Eastern Virginia Medical School | OB/GYN Clinical Research Center Norfolk Virginia 23507 —
Eastern Virginia Medical School Norfolk Virginia 23507 —
Virginia Physicians For Women North Chesterfield Virginia 23235 —
Seattle Clinical Research Center Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04614246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04614246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →